Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation
Abstract
BACKGROUND: 44Sc is becoming attractive as a PET radionuclide due to its decay characteristics. It can be produced from 44Ca present in natural calcium with 2.08% abundance.
MATERIALS AND METHODS: The targets were mostly prepared from natural CaCO3 or metallic calcium in the form of pellets. After irradiation they were dissolved in 3 M hydrochloric acid and 44Sc was separated from excess of calcium by precipitation of scandium hydroxide using ammonia. Alternatively, targets were dissolved in 11 M hydrochloric acid and 44Sc was separated by extraction chromatography on UTEVA resin. As the next step, in both processes 44Sc was further purified on a cation exchange resin. Initially, the separation procedures were developed with 46Sc as a tracer. Gamma spectrometry with a high purity germanium detector was used to determine the separation efficiency. Finally, the CaCO3 pellet with 99.2% enrichment in 44Ca was activated with protons via 44Ca(p,n)44Sc nuclear reaction.
RESULTS: Altogether twenty two irradiations and separations were performed. The working procedures were developed and the quality of separated 44Sc solution was confirmed by radiolabeling of DOTATATE. The chemical purity of the product was sufficient for preclinical experiments. At the end of around 1 hour proton beam irradiation of CaCO3 pellet with 99.2% enrichment in 44Ca the obtained radioactivity of 44Sc was more than 4.8 GBq.
CONCLUSION: 44Sc can be produced inexpensively with adequate yields and radionuclidic purity via 44Ca(p,n)44Sc nuclear reaction in small cyclotrons. The recovery yield in both investigated separation methods was comparable and amounted above 90%. The obtained 44Sc was pure in terms of radionuclide and chemical purity, as shown by the results of peptide radiolabeling.
Keywords: 44Sc productioncyclotronnatural calciumSc(OH)3 precipitationUTEVA extraction
References
- Eppard E, de la Fuente A, Benešová M, et al. Clinical Translation and First In-Human Use of [Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer. Theranostics. 2017; 7(18): 4359–4369.
- Minegishi K, Nagatsu K, Fukada M, et al. Production of scandium-43 and -47 from a powdery calcium oxide target via the (nat/44)Ca(α,x)-channel. Appl Radiat Isot. 2016; 116: 8–12.
- Valdovinos HF, Hernandez R, Barnhart TE, et al. Separation of cyclotron-produced Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin. Appl Radiat Isot. 2015; 95: 23–29.
- Severin GW, Engle JW, Valdovinos HF, et al. Cyclotron produced ⁴⁴gSc from natural calcium. Appl Radiat Isot. 2012; 70(8): 1526–1530.
- Kilian K, Cheda Ł, Sitarz M, et al. Separation of Sc from Natural Calcium Carbonate Targets for Synthesis of Sc-DOTATATE. Molecules. 2018; 23(7).
- van der Meulen NP, Bunka M, Domnanich KA, et al. Cyclotron production of (44)Sc: From bench to bedside. Nucl Med Biol. 2015; 42(9): 745–751.
- Müller C, Bunka M, Haller S, et al. Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice. J Nucl Med. 2014; 55(10): 1658–1664.
- Domnanich KA, Müller C, Farkas R, et al. Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharm Chem. 2017; 1(1): 8.
- Stolarz A, Kowalska JA, Jastrzębski J, et al. Targets for production of the medical radioisotopes with alpha and proton or deuteron beams. 2018.
- https://pubchem.ncbi.nlm.nih.gov/compound/calcium_carbonate#section=UNII.
